InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by BAILEY MICHAEL P, Chairman & CEO. Director active across 2 companies, notably Aveo Pharmaceuticals, INC.. In total, 5 reports have been published. Split: 2 buys · 0 sell. Total volume traded: €164k. History available since 1 September 2021. The latest transaction was filed on 21 May 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
5 of 5 declarations
Michael P. Bailey is the Chairman and CEO of AVEO Pharmaceuticals, Inc. He leads the company in the development of innovative treatments for cancer-related diseases. His leadership is crucial in guiding the company's strategy and ensuring its success in the pharmaceutical market.